Proposals for global excipient federation

29 March 2009

With the pharmaceutical sector increasingly operating on a global scale, supply chains for sourcing excipients are becoming more complex, and the  risk of errors caused by mislabeling, contamination or substitution of  one substance for another is increasing. In recognition of this  situation, the International Pharmaceutical Excipients Council has  responded with a proposal to create its own multi-regional body - to be  called the IPEC Federation - that will provide advocacy and promote  quality in excipients around the world.

For many years, the IPEC has consisted of three subdivisions -  IPEC-Americas, IPEC Europe and JPEC in Japan - which are known  collectively as TriPEC. The creation of IPEC China in 2008 provided an  opportunity to expand the horizons of the industry group and provide a  truly global platform for discussing issues relating to the quality,  safety and functionality of pharmaceutical excipients used in  pharmaceutical products.

Move supported regionally

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight